New Delhi: The Central GST authorities have passed an order against Torrent Pharma, imposing a penalty of Rs 41.33 crore, alleging that the company availed erroneous refunds on exports. The company, however, maintains that it will appeal and does not expect the order to have any material financial impact.
In a filing to the stock exchanges, Torrent Pharma informed that an Order dated 26 November 2025 had been issued by the Joint Commissioner, Common Adjudicating Authority, Central GST, Ahmedabad South Commissionerate. The filing states that the order was “received on 27th November, 2025.”
According to the official disclosure, the adjudicating authority has passed an order “under Section 74 of the Central Goods and Service Tax Act, 2017, imposing a penalty of ₹41,33,84,165/-.”
Allegation: Erroneous Refund on Export of Goods
Torrent Pharma revealed that the GST authority has alleged “erroneous refund by Department on export of goods.”
The filing does not detail the nature of the alleged error but Section 74 of the CGST Act typically deals with cases involving tax not paid, short paid, or erroneously refunded, where the department alleges fraud or wilful misstatement.
Company Says No Material Impact Expected
Torrent Pharma emphasised that while it will challenge the order, it expects no meaningful impact on its financials. The disclosure states:
“Based on the Company assessment, an appeal will be filed and the Company is hopeful of favorable outcome and does not reasonably expect the said Order to have any material financial impact on the Company.”
The company categorised the regulatory development as a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates timely reporting of material events to stock exchanges.
